# OMG

## Overview
The OMG gene encodes the oligodendrocyte myelin glycoprotein (OMgp), a glycosylphosphatidylinositol (GPI)-anchored protein predominantly expressed in the central nervous system (CNS). OMgp is a critical component of myelin, the insulating layer that surrounds nerve fibers, and plays a significant role in the formation and maintenance of myelin sheaths. It is involved in the structural organization of nodes of Ranvier, which are essential for rapid nerve signal transmission, and acts as a myelin-associated inhibitor by interacting with the Nogo receptor (NgR1) to inhibit neurite outgrowth (Wang2002Oligodendrocytemyelin; NIE2006Oligodendrocytes). The protein's structure includes leucine-rich repeats and a cysteine-rich motif, which facilitate its interactions with other proteins and contribute to its function in axoglial interactions during myelination (Wang2002Oligodendrocytemyelin; Mikol1990The). Mutations in the OMG gene have been associated with neurological conditions, underscoring its importance in CNS function and development (Venturin2006Mutations).

## Structure
The oligodendrocyte-myelin glycoprotein (OMgp) is a glycophospholipid-linked membrane protein primarily expressed in the central nervous system (CNS) myelin. The primary structure of OMgp consists of 433 amino acids, including a 17-amino acid leader sequence. It is composed of four distinct domains: a short cysteine-rich motif at the NH2 terminus, a series of tandem leucine-rich repeats (LRs), a serine/threonine-rich region, and a hydrophobic COOH-terminal segment (Mikol1990The).

The NH2-terminal domain contains four cysteines arranged similarly to epidermal growth factor (EGF) motifs, although it is referred to as a cysteine-rich motif due to having only four cysteines (Mikol1990The). The LRs, which are approximately 24 amino acids long, are followed by serine/threonine-rich repeats that carry O-linked carbohydrates (Mikol1990The). The COOH-terminal region is hydrophobic and likely serves as a signal for glycosylphosphatidylinositol (GPI) attachment, which is cleaved during biosynthesis (Mikol1990The).

OMgp is highly glycosylated, containing at least 25 kD of N-linked carbohydrates, with nine potential asparagine-linked oligosaccharide attachment sites (Mikol1990The). A subpopulation of OMgp molecules contains the HNK-1 carbohydrate, which may mediate cell adhesion (Mikol1990The).

## Function
The oligodendrocyte myelin glycoprotein (OMgp) is a crucial component in the central nervous system, primarily involved in the formation and stabilization of myelin sheaths around nerve fibers. OMgp plays a significant role in the formation and maintenance of nodes of Ranvier, which are essential for rapid nerve signal transmission. It aggregates specifically at these nodes, contributing to the structural integrity and proper function of myelinated axons (NIE2006Oligodendrocytes). 

OMgp is expressed predominantly by oligodendrocytes and is involved in axoglial interactions during myelination. It stabilizes the lateral oligodendrocyte loops that anchor to the axon surface, demarcating nodal and paranodal domains, which are critical for efficient nerve conduction (NIE2006Oligodendrocytes). Despite its role in structural organization, OMgp does not directly influence Na+ currents, although it is important for proper axonal conduction (NIE2006Oligodendrocytes).

OMgp also acts as a potent inhibitor of neurite outgrowth by binding to the Nogo receptor (NgR), which is involved in inhibiting axon regeneration. This interaction is crucial for maintaining the stability and integrity of the myelin sheath, impacting neural communication and overall nervous system function (Wang2002Oligodendrocytemyelin).

## Clinical Significance
Mutations and alterations in the OMG gene, which encodes oligodendrocyte myelin glycoprotein, have been implicated in various neurological conditions. In patients with non-syndromic mental retardation, several novel mutations in the OMG gene have been identified, including a missense mutation c.1222A>G (p.T408A) and changes in the 5′ untranslated region (UTR). These mutations are absent in healthy individuals, suggesting their potential significance in mental retardation. The p.T408A mutation, in particular, may cause conformational changes in the protein, potentially affecting its function in the central nervous system (Venturin2006Mutations).

The OMG gene is also involved in Nogo-type signaling, a pathway that regulates synaptic plasticity in the central nervous system. Although a study investigating the association between Nogo-type signaling genes, including OMGP, and migraine found no significant link, the role of OMG in neurological disorders remains an area of interest (Smedfors2019Genetic). The potential involvement of OMG in these conditions highlights the importance of further research to understand its role in neurodevelopmental and neurodegenerative diseases.

## Interactions
Oligodendrocyte myelin glycoprotein (OMgp) is known to interact with several proteins, primarily through its role as a myelin-associated inhibitor in the central nervous system. OMgp is a glycosylphosphatidylinositol (GPI)-anchored protein that binds to the Nogo receptor (NgR1), a high-affinity receptor for myelin-associated inhibitors. This interaction is crucial for OMgp's function in inhibiting neurite outgrowth. The binding affinity of NgR1 for OMgp is approximately 5 nM, which is similar to its affinity for Nogo-66, another myelin-associated inhibitor (Wang2002Oligodendrocytemyelin).

OMgp also interacts with other components of the NgR1 receptor complex, including co-receptors such as p75 NTR and TROY, which are members of the TNF receptor family. These interactions facilitate the transduction of inhibitory signals that lead to growth cone collapse and inhibition of axon growth (Zheng2014Myelinassociated). Additionally, OMgp can bind to paired immunoglobulin-like receptor B (PirB), which is another receptor involved in axonal growth inhibition (Geoffroy2015MyelinAssociated).

The leucine-rich repeat (LRR) domain of OMgp is sufficient for its binding to NgR1-expressing cells, indicating that this domain plays a significant role in its interactions with other proteins (Wang2002Oligodendrocytemyelin).


## References


[1. (Geoffroy2015MyelinAssociated) Cédric C. Geoffroy and Binhai Zheng. Myelin-Associated Inhibitors in Axonal Growth after Central Nervous System Injury, pages 153–170. Elsevier, 2015. URL: http://dx.doi.org/10.1016/b978-0-12-801732-6.00009-4, doi:10.1016/b978-0-12-801732-6.00009-4. This article has 1 citations.](https://doi.org/10.1016/b978-0-12-801732-6.00009-4)

[2. (Smedfors2019Genetic) Gabriella Smedfors, Franziska Liesecke, Caroline Ran, Lars Olson, Tobias Karlsson, and Andrea Carmine Belin. Genetic screening of plasticity regulating nogo-type signaling genes in migraine. Brain Sciences, 10(1):5, December 2019. URL: http://dx.doi.org/10.3390/brainsci10010005, doi:10.3390/brainsci10010005. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/brainsci10010005)

[3. (Zheng2014Myelinassociated) Binhai Zheng and Karim Fouad. Myelin-associated axon growth inhibitors, pages 339–348. Cambridge University Press, April 2014. URL: http://dx.doi.org/10.1017/cbo9780511995583.026, doi:10.1017/cbo9780511995583.026. This article has 0 citations.](https://doi.org/10.1017/cbo9780511995583.026)

[4. (Wang2002Oligodendrocytemyelin) Kevin C. Wang, Vuk Koprivica, Jieun A. Kim, Rajeev Sivasankaran, Yong Guo, Rachel L. Neve, and Zhigang He. Oligodendrocyte-myelin glycoprotein is a nogo receptor ligand that inhibits neurite outgrowth. Nature, 417(6892):941–944, June 2002. URL: http://dx.doi.org/10.1038/nature00867, doi:10.1038/nature00867. This article has 743 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature00867)

[5. (NIE2006Oligodendrocytes) DU-YU NIE, QUAN-HONG MA, JANICE W.S. LAW, CHERN-PANG CHIA, NARENDER K. DHINGRA, YASUSHI SHIMODA, WU-LIN YANG, NENG GONG, QING-WEN CHEN, GANG XU, QI-DONG HU, PIERCE K.H. CHOW, YEE-KONG NG, ENG-ANG LING, KAZUTADA WATANABE, TIAN-LE XU, AMYN A. HABIB, MELITTA SCHACHNER, and ZHI-CHENG XIAO. Oligodendrocytes regulate formation of nodes of ranvier via the recognition molecule omgp. Neuron Glia Biology, 2(3):151–164, July 2006. URL: http://dx.doi.org/10.1017/s1740925x06000251, doi:10.1017/s1740925x06000251. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1017/s1740925x06000251)

[6. (Venturin2006Mutations) Marco Venturin, Silvia Moncini, Valentina Villa, Silvia Russo, Maria Teresa Bonati, Lidia Larizza, and Paola Riva. Mutations and novel polymorphisms in coding regions and utrs of cdk5r1 and omg genes in patients with non-syndromic mental retardation. Neurogenetics, 7(1):59–66, January 2006. URL: http://dx.doi.org/10.1007/s10048-005-0026-9, doi:10.1007/s10048-005-0026-9. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10048-005-0026-9)

[7. (Mikol1990The) D D Mikol, J R Gulcher, and K Stefansson. The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the hnk-1 carbohydrate. The Journal of cell biology, 110(2):471–479, February 1990. URL: http://dx.doi.org/10.1083/jcb.110.2.471, doi:10.1083/jcb.110.2.471. This article has 115 citations.](https://doi.org/10.1083/jcb.110.2.471)